- My News
- All News
- Most Popular
"Our collaboration has vastly accelerated the availability of this rapid, high-throughput assay that is easy-to-use, reliable, cost-effective and allows up to 94 patient samples per 1.5 hours. As a key player in the field of real-time PCR diagnostics, we have responded to the global pandemic by launching our Magnetic Preparation Kit VI for viral RNA extraction and purification. Our kit works hand-in-hand with this real-time PCR assay to accurately detect the SARS-CoV-2 virus and therefore support mass diagnostic efforts," said Alois Schneiderbauer, the Chief Business Officer of BIOTECON Diagnostics.
"We are very pleased to be actively supporting laboratories worldwide by providing first-in-class extraction and detection solutions. Detection that is carried out by real-time PCR is the method we have adopted for over 20 years. In combination with automation solutions, it not only enables high volume processing but also provides rapid decision-making reliability," Alois Schneiderbauer concluded.
*Worldwide exclusive distribution rights excluding Singapore, Malaysia, and Indonesia.
**Approved "for research use only," CE-IVD pending. Approval from the Food and Drug Administration (FDA) for an Emergency Use Authorization (EUA) pending.
SOURCE BIOTECON Diagnostics GmbH
Did you like this article?